ORNL Mice Helping Researchers Isolate, Identify Causes Of Cancer

January 07, 1997

OAK RIDGE, Tenn. -- Mice may have a reputation for being quiet, but they're telling researchers at the Department of Energy's (DOE) Oak Ridge National Laboratory (ORNL) something about the causes of leukemia, lymphoma and other illnesses in people.

"Lymphomas that develop spontaneously in the mouse are very useful for our studies because mouse leukemias and lymphomas are very similar to human leukemias," said Monica Justice, a genetics researcher in ORNL's Biology Division. "In addition, mouse lymphomas have genetic characteristics that allow us to isolate the genes involved in the development of the cancer."

Included in ORNL's inventory of 120,000 mice are 1,000 strains, some of which were originally bred to study the genetics of cancer.

"Some of these mouse strains have a high spontaneous incidence of lymphoma and/or leukemia," Justice said.

When these mouse strains were first developed, scientists didn't know the reason the mice developed leukemia. Now, however, Justice and colleagues know that the mice get cancer because of murine leukemia retroviruses.

"One way these retroviruses can cause cancer is to integrate near and change the normal function of cancer-causing genes," Justice said. Molecular probes for the retroviruses provide researchers with "tags" to identify genes that cause cancer. By studying the normal role of these genes that ultimately cause cancer in mice, Justice hopes to understand their role in cancerous growth when they are altered by the retrovirus.

In addition to her work with murine leukemia retroviruses, Justice has discovered a direct correlation between Chediak Higashi Syndrome in humans to what's simply called "beige" in mice. In people, the syndrome causes partial albinism, an increased susceptibility to infections and a predisposition to non-malignant lymphoma. Beige mice have the same clinical symptoms as humans.

This similarity in diseases, along with comparative mapping studies, led Justice and collaborators to trace the mouse gene in an effort to learn the cause of the human disease. Justice and colleagues identified the disease gene in mice and used the mouse gene to identify the human gene. This information has led to the discovery of the cause of clinical symptoms in humans.

Because of the genetic similarity between mice and humans, researchers hope to gain a better understanding of the development of certain human cancers, to earlier diagnoses and to better treatment strategies.

This research was funded by the National Cancer Institute and the American Cancer Society.

ORNL, one of DOE's multiprogram research facilities, is managed by Lockheed Martin Energy Research Corp. You may read other press releases from Oak Ridge National Laboratory or learn more about the lab if you have access to the Internet. You can find our information on the World Wide Web at http://www.ornl.gov

DOE/Oak Ridge National Laboratory

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.